4CQ-25691-58382
1 vaccination
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 670 / KS
- Registered
- 2020-12-18
- Relationship
- Self
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-31
-
2021-01-07
Survey response — day 21, dose 1MedDRA: Anosmia, COVID-19, Cough, Dyspnoea, Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Diagnosed with COVID. short o breath, coughing, loss of smell, excessive tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-07 | Unsuccessful |
Free text
Release 1 — day 21, dose 1
Symptoms: Diagnosed with COVID. short o breath, coughing, loss of smell, excessive tiredness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release